How to improve exposure of tumor cells to drugs — Promoter drugs increase tumor uptake and penetration of effector drugsMARCUCCI, Fabrizio; CORTI, Angelo.Advanced drug delivery reviews. 2012, Vol 64, Num 1, pp 53-68, issn 0169-409X, 16 p.Article

Improving drug penetration to curb tumor drug resistanceMARCUCCI, Fabrizio; CORTI, Angelo.Drug discovery today. 2012, Vol 17, Num 19-20, pp 1139-1146, issn 1359-6446, 8 p.Article

Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor α coupled to NGR and RGD tumor-homing peptidesZAROVNI, Natasa; MONACO, Lucia; CORTI, Angelo et al.Human gene therapy. 2004, Vol 15, Num 4, pp 373-382, issn 1043-0342, 10 p.Article

The neovasculature homing motif NGR : more than meets the eyeCORTI, Angelo; CURNIS, Flavio; ARAP, Wadih et al.Blood. 2008, Vol 112, Num 7, pp 2628-2635, issn 0006-4971, 8 p.Article

New approaches to improve the therapeutic index of Tumor Necrosis Factor α (TNF)CORTI, Angelo; CURNIS, Flavio.Recent research developments in cancer : Vol. 3 (2001) - Part II. Recent research developments in quantum electronics. 2001, pp 69-78, isbn 81-7895-002-2Book Chapter

Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colonAMATO, Antonella; CORTI, Angelo; SERIO, Rosa et al.Regulatory peptides. 2005, Vol 130, Num 1-2, pp 42-47, issn 0167-0115, 6 p.Article

Crucial role for interferon γ in the synergism between tumor vasculature-targeted tumor necrosis factor α (NGR-TNF) and doxorubicinSACCHI, Angelina; GASPARRI, Anna; CURNIS, Flavio et al.Cancer research (Baltimore). 2004, Vol 64, Num 19, pp 7150-7155, issn 0008-5472, 6 p.Article

Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roadsMARCUCCI, Fabrizio; BELLONE, Matteo; CASERTA, Carmelo Antonio et al.International journal of cancer (Print). 2014, Vol 135, Num 6, pp 1265-1276, issn 0020-7136, 12 p.Article

Chromogranin A Regulates Tumor Self-Seeding and DisseminationDONDOSSOLA, Eleonora; CRIPPA, Luca; COLOMBO, Barbara et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 2, pp 449-459, issn 0008-5472, 11 p.Article

Coupling tumor necrosis factor-α with α_V integrin ligands improves its antineoplastic activityCURNIS, Flavio; GASPARRI, Anna; SACCHI, Angelina et al.Cancer research (Baltimore). 2004, Vol 64, Num 2, pp 565-571, issn 0008-5472, 7 p.Article

Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancerGREGORC, Vanesa; SPREAFICO, Anna; FLORIANI, Irene et al.Cancer. 2007, Vol 110, Num 4, pp 845-853, issn 0008-543X, 9 p.Article

Roles of tumor necrosis factor p55 and p75 receptors in TNF-α-induced vascular permeabilityFERRERO, Elisabetta; ZOCCHI, Maria Raffaella; MAGNI, Elena et al.American journal of physiology. Cell physiology. 2001, Vol 50, Num 4, pp C1173-C1179, issn 0363-6143Article

Full-Length Human Chromogranin-A Cardioactivity: Myocardial, Coronary, and Stimulus-Induced Processing Evidence in Normotensive and Hypertensive Male Rat HeartsPASQUA, Teresa; CORTI, Angelo; GENTILE, Stefano et al.Endocrinology (Philadelphia). 2013, Vol 154, Num 9, pp 3353-3365, issn 0013-7227, 13 p.Article

Vasculature-Targeted Tumor Necrosis Factor-Alpha Increases theTherapeutic Index of Doxorubicin Against Prostate CancerBERTILACCIO, Maria T. S; GRIONI, Matteo; SUTHERLAND, Brent W et al.The Prostate. 2008, Vol 68, Num 10, pp 1105-1115, issn 0270-4137, 11 p.Article

Characterisation of functional biotinylated TNF-α targeted to the membrane of apoptotic melanoma cellsZIMMERMANN, Valérie S; BONDANZA, Attilio; ROVERE-QUERINI, Patrizia et al.Journal of immunological methods. 2003, Vol 276, Num 1-2, pp 79-87, issn 0022-1759, 9 p.Article

Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)CURNIS, Flavio; SACCHI, Angelina; BORGNA, Laura et al.Nature biotechnology. 2000, Vol 18, Num 11, pp 1185-1190, issn 1087-0156Article

Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumoursGREGORC, Vanesa; CITTERIO, Giovanni; DEL MASCHIO, Alessandro et al.European journal of cancer (1990). 2010, Vol 46, Num 1, pp 198-206, issn 0959-8049, 9 p.Article

Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA_1-64) in the rat heartANGELONE, Tommaso; QUINTIERI, Anna Maria; CARMELA CERRA, Maria et al.Regulatory peptides. 2010, Vol 165, Num 1, pp 78-85, issn 0167-0115, 8 p.Article

Myocardial production of chromogranin A in human heart : a new regulatory peptide of cardiac function. CommentarySCHULZE, Paul Christian; PIERONI, Maurizio; MASERI, Attilio et al.European heart journal. 2007, Vol 28, Num 9, issn 0195-668X, 1052-1053,1117-1127 [13 p.]Article

Peptide microarrays for the characterization of antigenic regions of human chromogranin ACHIARI, Marcella; CRETICH, Marina; CORTI, Angelo et al.Proteomics (Weinheim. Print). 2005, Vol 5, Num 14, pp 3600-3603, issn 1615-9853, 4 p.Article

Synergistic antitumor activity of cisplatin, paclitaxel, and gemcitabine with tumor vasculature-targeted tumor necrosis factor-αSACCHI, Angelina; GASPARRI, Anna; GALLO-STAMPINO, Corrado et al.Clinical cancer research. 2006, Vol 12, Num 1, pp 175-182, issn 1078-0432, 8 p.Article

The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cellsBLOIS, Anna; SREBRO, Boleslaw; MANDALA, Maurizio et al.Regulatory peptides. 2006, Vol 135, Num 1-2, pp 78-84, issn 0167-0115, 7 p.Article

Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cellsCURNIS, Flavio; ARRIGONI, Gianluigi; SACCHI, Angelina et al.Cancer research (Baltimore). 2002, Vol 62, Num 3, pp 867-874, issn 0008-5472Article

Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic EfficacyDONDOSSOLA, Eleonora; GASPARRI, Anna Maria; COLOMBO, Barbara et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5881-5890, issn 0008-5472, 10 p.Article

Targeted delivery of IFNγ to tumor vessels uncouples antitumor from counterregulatory mechanismsCURNIS, Flavio; GASPARRI, Anna; SACCHI, Angelina et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2906-2913, issn 0008-5472, 8 p.Article